Novavax, Inc.
NVAX
$7.95
-$0.005-0.06%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 65.60% | 48.11% | 49.84% | 65.49% | 17.16% |
| Total Depreciation and Amortization | 17.64% | 24.22% | 30.90% | 41.48% | 41.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -98.05% | -55.64% | -72.99% | -75.11% | -70.96% |
| Change in Net Operating Assets | 112.87% | 112.90% | 126.46% | -139.66% | -4.34% |
| Cash from Operations | 87.78% | 86.13% | 102.18% | 27.73% | -71.65% |
| Capital Expenditure | 75.72% | 70.62% | 50.62% | 55.61% | 39.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7,519.15% | -8,687.05% | -4,265.00% | 78.53% | -28.15% |
| Cash from Investing | -246.97% | -397.44% | -391.35% | 57.38% | 36.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 98.87% | 99.11% | 99.70% | 99.68% | -276.46% |
| Issuance of Common Stock | -26.40% | 12.36% | 326.09% | 421.50% | 43.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | 100.00% | 93.51% | 39.10% |
| Cash from Financing | 5,734.82% | 281.50% | 523.60% | 292.72% | -98.63% |
| Foreign Exchange rate Adjustments | -338.39% | 26.33% | 48,273.68% | 268.26% | -27.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 94.97% | 87.59% | 120.43% | 85.11% | -326.41% |
